Nattawat Klomjit, MD, FASN
I am an Assistant Professor of Medicine at the University of Minnesota. I obtained my medical degree
from the Siriraj Hospital, Mahidol University with Magna Cum Laude in 2011. I was a research assistant
at the Kidney and Pancreas transplant center at the University of California Los Angelis (UCLA) in 2014. I
then joined the Internal Medicine Residency Program at the University of Hawaii (2015-2018).
Subsequently, I pursued nephrology fellowship at the Mayo Clinic Rochester (2018-2021) where I have
received the best clinical fellow award in 2021. During my fellowship year, I also received the travel
grant awards for the annual dialysis conference for 2 consecutive years (2019-2020). After graduation, I
joined the division of nephrology and hypertension at the University of Minnesota in July 2021. I am
both board certified in Internal Medicine and Nephrology. I am passionate in patient care, research and
education with particular interest in glomerulonephritis, onconephrology and thrombotic
microangiopathy. Glomerulonephritis is the kidney condition caused by autoimmune or inflammatory
process. These conditions include but not limited to ANCA-vasculitis, lupus nephritis, IgA nephropathy,
minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy and etc. I also
started the Onconephrology clinic at the University of Minnesota in July 2021. This clinic primarily serves
cancers patients who have kidney problems with the goal to preserve kidney functions and ameliorate
kidney damages from cancers or their therapy. Currently, I am one of the committee member in the
American Society of Onconephrology in Research and Positional Statement section. Moreover, I also
have expertise in thrombotic microangiopathy (TMA) and atypical hemolytic uremic syndrome (aHUS).
These conditions are often overlooked and resulted in poor clinical outcomes requiring multi-disciplinary
(nephrology, hematology-oncology and etc.) approach.